Lingling Li

1.4k citations
29 papers · 308 indexed · h-index 10
Topics
Lung Cancer Research Studies (6 papers)Neuroendocrine Tumor Research Advances (5 papers)Lung Cancer Treatments and Mutations (4 papers)

In The Last Decade

Lingling Li

26 papers receiving 305 citations

Peers

Lingling Li
Comparison fields: 5 of 68
  • Oncology 120
  • Molecular Biology 105
  • Pulmonary and Respiratory Medicine 78
  • Epidemiology 62
  • Cancer Research 53
Replace Hyejeong Jang with:
Hyejeong Jang United States
Osman Manavoğlu Türkiye
Alice M. Boylan United States
Sara A. Väyrynen Finland
Zuojian Hu China
Laura Succony United Kingdom
Helén Tuvesson Sweden
Yunyan Wan China
Babar Bashir United States
Lingling Li relative to Hyejeong Jang United States Hyejeong Jang's profile →
Citations per field
00.5×
Hyejeong Jang · 1×
Citations per year

Countries citing papers authored by Lingling Li

Since Specialization
Citations

This map shows the geographic impact of Lingling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingling Li more than expected).

Fields of papers citing papers by Lingling Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingling Li. The network helps show where Lingling Li may publish in the future.

Co-authorship network of co-authors of Lingling Li

This figure shows the co-authorship network connecting the top 25 collaborators of Lingling Li. A scholar is included among the top collaborators of Lingling Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingling Li. Lingling Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 0
5 6
6 7
7 15
8 7
9 20
10 16
11 10
12 8
13 15
14 10
15 3
16 83
17 1
18 1
19
[Nutritional risk screening and nutrition assessment for gastrointestinal cancer patients].
6
20 1

About Lingling Li

Lingling Li is a scholar working on Oncology, Internal Medicine and Geriatrics and Gerontology, having authored 29 papers that have together received 308 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (6 papers), Neuroendocrine Tumor Research Advances (5 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Oncology (120 citations), Cancer Research (53 citations) and Pulmonary and Respiratory Medicine (78 citations). Lingling Li has collaborated with scholars based in China, United States and Malaysia. Frequent co-authors include Yi Hu, Sujie Zhang, Wei Yao, Zhongyi Fan, Shunchang Jiao, Jie Yang, Zhiwei Lu, Jingjing Duan, Ye Li and Xiang Yan. Their work appears in journals such as Journal of Clinical Oncology, Biochemical Pharmacology and Cancer Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026